臨床試驗

INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac Recovery

NCT：NCT06965504 · NOT_YET_RECRUITING

NCT IDNCT06965504

狀態NOT_YET_RECRUITING

開始日期2026-09-01

完成時間2029-06-01

SponsorAbiomed Inc. (INDUSTRY)

First posted2025-05-11

Last updated2026-09-10

簡要摘要

The study will evaluate the impact of a combined device-drug strategy with Impella 5.5 with best practices and optimized GDMT on heart recovery outcomes in patients with decompensated heart failure and cardiogenic shock.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。